Description
SWOT ANALYSIS OF ST. JUDE MEDICAL
St Jude Medical
Parent Company
St Jude Medical
Category
Healthcare
Sector
Medical technology and services
Tagline/ Slogan
More Control. Less Risk
invests in technologies that improve patient care while reducing the economic burden of epidemic diseases like heart failure, hypertension, coronary artery disease, depression and migraine on global health care USP systems.
STP
Cardiac rhythm management, Atrial fibrillation, Cardiovascular and Segment Neuromodulation.
People who treat cardiac, neurological and chronic pain patients, Target Group worldwide
Advancing the practice of medicine by reducing risk wherever possible Positioning and contributing to successful outcomes for every patient.
SWOT Analysis
1. Sells products in more than 100 countries and has over 20 operations and manufacturing facilities worldwide 2. Balanced portfolio of major new growth drivers 3. Recognized by FORTUNE magazine as one of America’s Most Admired Companies for six consecutive years 4. Joint marketing partnership with Abbott Laboratories Strength 5. Strong brand name and widespread operations
1.Product recall due to device failure resulting in negative publicity 2.Employment and financial problems in recent years – characterized Weakness by elimination of global work force
1.Acquisitions and mergers to improve product portfolio 2.Word on brand image and brand recall 3.Increase geographical reach with more manufacturing and Opportunity distribution outlets
1. Technological capabilities of competitors 2.Competition at international level Threats 3.FDA sanctions/warnings over product portfolio
Competition
1.Medtronic Inc 2.Boston Scientific Corporation Competitors 3.Edwards Lifesciences Corporation
doc_882999192.docx
SWOT ANALYSIS OF ST. JUDE MEDICAL
St Jude Medical
Parent Company
St Jude Medical
Category
Healthcare
Sector
Medical technology and services
Tagline/ Slogan
More Control. Less Risk
invests in technologies that improve patient care while reducing the economic burden of epidemic diseases like heart failure, hypertension, coronary artery disease, depression and migraine on global health care USP systems.
STP
Cardiac rhythm management, Atrial fibrillation, Cardiovascular and Segment Neuromodulation.
People who treat cardiac, neurological and chronic pain patients, Target Group worldwide
Advancing the practice of medicine by reducing risk wherever possible Positioning and contributing to successful outcomes for every patient.
SWOT Analysis
1. Sells products in more than 100 countries and has over 20 operations and manufacturing facilities worldwide 2. Balanced portfolio of major new growth drivers 3. Recognized by FORTUNE magazine as one of America’s Most Admired Companies for six consecutive years 4. Joint marketing partnership with Abbott Laboratories Strength 5. Strong brand name and widespread operations
1.Product recall due to device failure resulting in negative publicity 2.Employment and financial problems in recent years – characterized Weakness by elimination of global work force
1.Acquisitions and mergers to improve product portfolio 2.Word on brand image and brand recall 3.Increase geographical reach with more manufacturing and Opportunity distribution outlets
1. Technological capabilities of competitors 2.Competition at international level Threats 3.FDA sanctions/warnings over product portfolio
Competition
1.Medtronic Inc 2.Boston Scientific Corporation Competitors 3.Edwards Lifesciences Corporation
doc_882999192.docx